Australia Revises GMPs for Human Blood, Tissue Products

Australia’s Therapeutic Goods Administration has released revisions to 2,000 GMP codes that apply to biologic drugs, blood and tissue components and cellular therapy products. Set to take effect at the end of last month, the Australian Code of Good Manufacturing Practice for Blood and Blood Components, Human Tissues and Human Cellular Therapy Products applies to manufacturers that collect, process, test, store and release biologic drugs and supplies.
Drug GMP Report